David J. Schlanger - 11 Feb 2022 Form 4 Insider Report for Progyny, Inc. (PGNY)

Role
Executive Chairman, Director
Signature
/s/ Jennifer Bealer, Attorney-in-Fact
Issuer symbol
PGNY
Transactions as of
11 Feb 2022
Net transactions value
-$41,090
Form type
4
Filing time
15 Feb 2022, 20:09:05 UTC
Previous filing
05 Jan 2022
Next filing
17 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGNY Common Stock Options Exercise $910 +1,000 +1.2% $0.9100* 85,000 11 Feb 2022 Direct
transaction PGNY Common Stock Sale $42,000 -1,000 -1.2% $42.00 84,000 11 Feb 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGNY Employee Stock Option (Right to Buy) Options Exercise $0 -1,000 -0.05% $0.000000 2,182,680 11 Feb 2022 Common Stock 1,000 $0.9100 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.0050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F3 One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date.